查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956799

伴侣动物健康市场分析及预测（至2035年）：依类型、产品类型、服务、技术、组件、应用、设备、最终用户、解决方案、模式

Companion Animal Health Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 374 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，伴侣动物健康市场规模将从2024年的154亿美元成长至312亿美元，年复合成长率约为6.6%。该市场涵盖旨在维护和改善宠物健康的各类产品和服务（例如动物医药、诊断试剂和营养补充剂）。宠物主人数量的增加和人们对动物健康的意识提升推动了该市场的强劲增长。兽医学、个人化医疗和预防保健领域的创新是关键驱动因素，加上宠物保险和健康管理计画的扩展，这些因素共同促进了伴侣动物生活品质的提升。

受宠物主人数量不断增长和动物福利意识提升的推动，伴侣动物健康市场正经历强劲增长。医药领域在该市场中占据主导地位，这得益于兽医学的进步和针对慢性疾病的标靶治疗的开发。疫苗，尤其是犬猫疫苗，是成长第二快的细分市场，反映了医疗保健干预措施的扩展。诊断领域也取得了显着成长，院内诊断工具和就地检验的重要性日益凸显。这些创新使得及时、准确的健康评估成为可能，从而提高了兽医服务的品质。专注于疾病管理和针对不同生命阶段营养的营养产品越来越受欢迎，进一步推动了市场成长。此外，远端医疗服务的兴起为远端咨询和监测提供了新的机会，满足了宠物饲主不断变化的需求。对研发和策略伙伴关係的投资对于维持市场成长动能和应对伴侣动物领域新出现的健康挑战至关重要。

市场区隔
类型 疫苗、药品、饲料添加物、诊断试剂、治疗药物、营养补充品、生物製药
产品 动物用药品、宠物食品、动物营养补充品、医疗设备、穿戴式设备
服务 兽医诊所、宠物美容、宠物饭店、宠物训练、宠物保险
科技 数位健康、远端医疗、穿戴式科技、基因组学、生物技术、人工智慧
成分 软体、硬体和服务
应用 疾病治疗、预防医学、营养管理、康復
装置 监测、治疗和诊断设备
最终用户 兽医诊所、居家照护机构和研究机构
解决方案 临床、营运和财务解决方案
模式 现场诊疗、远距监测和远端医疗

伴侣动物健康市场正经历市场份额、定价策略和产品创新方面的动态变化。主要企业正策略性地推出新产品，以满足日益增长的先进动物保健解决方案的需求。该市场的特点是产品种类繁多，涵盖从预防保健到复杂治疗的各种健康需求。定价策略也不断演变，以应对竞争压力和消费者期望，重点在于透过提高疗效和客户满意度来创造价值。在竞争标竿方面，主要参与者正透过创新和策略联盟不断实现差异化。监管影响至关重要，严格的指导方针塑造产品开发和打入市场策略。对动物福利的日益重视以及通用感染疾病的增加也对市场产生影响。竞争格局的特点是跨国公司和新兴区域企业并存，它们正竞相透过技术创新和拓展分销网络来巩固自身地位。

主要趋势和驱动因素：

受宠物饲养率上升和动物福利意识增强的推动，伴侣动物健康市场正经历强劲增长。一个显着的趋势是，对先进兽医诊断和治疗方法的需求激增，这反映出人们对预防保健和疾病早期发现的重视。远端照护和穿戴式宠物健康监测设备等技术创新正在透过带来便利和改善健康结果来改变市场格局。另一个关键驱动因素是宠物的人性化。饲主愿意投资高级产品和服务，这推动了宠物营养和个人化医疗等领域的创新。兽医诊所和宠物医疗保健基础设施的扩张，尤其是在新兴市场，也促进了市场成长。此外，产业参与者之间的策略联盟和合作正在促进新解决方案的开发和市场扩张。尤其是在兽医服务资源有限的地区，开发经济高效的治疗方法和诊断工具存在着巨大的机会。专注于研发解决伴侣动物特定健康问题的公司，将能更好地掌握这些趋势带来的机会。对永续和环保产品的重视与消费者对环保选择的广泛偏好相一致，进一步塑造了市场。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 疫苗
    • 製药
    • 饲料添加剂
    • 诊断试剂
    • 治疗药物
    • 营养保健品
    • 生物製药
  • 市场规模及预测：依产品划分
    • 动物用药品
    • 宠物食品
    • 动物补充品
    • 医疗设备
    • 穿戴式装置
  • 市场规模及预测：依服务划分
    • 兽医诊所
    • 宠物美容
    • 宠物寄宿服务
    • 宠物训练
    • 宠物保险
  • 市场规模及预测：依技术划分
    • 数位健康
    • 远端医疗
    • 穿戴式科技
    • 基因组学
    • 生物技术
    • 人工智慧
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
    • 服务
  • 市场规模及预测：依应用领域划分
    • 疾病治疗
    • 预防医学
    • 营养管理
    • 復原
  • 市场规模及预测：依设备划分
    • 监测设备
    • 治疗设备
    • 诊断设备
  • 市场规模及预测：依最终用户划分
    • 兽医诊所
    • 居家照护环境
    • 研究所
  • 市场规模及预测：按解决方案划分
    • 临床解决方案
    • 营运解决方案
    • 金融解决方案
  • 市场规模及预测：按模式
    • 面对面
    • 远端监控
    • 远端医疗

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Vetoquinol
  • Dechra Pharmaceuticals
  • Virbac
  • Heska Corporation
  • Zoetis
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Phibro Animal Health
  • IDEXX Laboratories
  • Merck Animal Health
  • Bimeda
  • Neogen Corporation
  • Kyoritsu Seiyaku
  • Ourofino Saude Animal
  • Bio Chek
  • Vetcare
  • Norbrook Laboratories
  • Hipra
  • Eco Animal Health

第九章：关于我们

简介目录
Product Code: GIS21322

Companion Animal Health Market is anticipated to expand from $15.4 billion in 2024 to $31.2 billion by 2034, growing at a CAGR of approximately 6.6%. The Companion Animal Health Market encompasses products and services aimed at maintaining and improving the health of pets, including veterinary pharmaceuticals, diagnostics, and nutritional supplements. With rising pet ownership and increasing awareness of animal health, this market is experiencing robust growth. Innovations in veterinary care, personalized medicine, and preventive healthcare are key drivers, alongside the expansion of pet insurance and wellness programs, enhancing the quality of life for companion animals.

The Companion Animal Health Market is experiencing robust growth, propelled by rising pet ownership and increasing awareness of animal welfare. Within this market, the pharmaceuticals segment leads, driven by advancements in veterinary medicine and the development of targeted treatments for chronic conditions. Vaccines, particularly for canine and feline species, represent the second highest performing sub-segment, reflecting growing preventive healthcare measures. The diagnostics segment is also witnessing significant expansion, with in-clinic diagnostic tools and point-of-care testing gaining prominence. These innovations enable timely and accurate health assessments, enhancing veterinary care. Nutritional products, focusing on specialized diets for disease management and life stage-specific nutrition, are increasingly popular, further supporting market growth. Additionally, the rise of telemedicine services offers new opportunities for remote consultations and monitoring, catering to the evolving needs of pet owners. Investment in research and development, alongside strategic partnerships, is crucial for sustaining market momentum and addressing emerging health challenges in companion animals.

Market Segmentation
TypeVaccines, Pharmaceuticals, Feed Additives, Diagnostics, Therapeutics, Nutraceuticals, Biologics
ProductVeterinary Drugs, Pet Food, Animal Supplements, Medical Devices, Wearable Devices
ServicesVeterinary Clinics, Pet Grooming, Pet Boarding, Pet Training, Pet Insurance
TechnologyDigital Health, Telemedicine, Wearable Technology, Genomics, Biotechnology, Artificial Intelligence
ComponentSoftware, Hardware, Services
ApplicationDisease Treatment, Preventive Care, Nutrition Management, Rehabilitation
DeviceMonitoring Devices, Therapeutic Devices, Diagnostic Devices
End UserVeterinary Hospitals, Home Care Settings, Research Institutes
SolutionsClinical Solutions, Operational Solutions, Financial Solutions
ModeIn-Person, Remote Monitoring, Telehealth

The Companion Animal Health Market is witnessing a dynamic shift in market share, pricing strategies, and product innovation. Leading companies are strategically launching new products to meet the growing demand for advanced animal healthcare solutions. The market is characterized by a diverse range of offerings that address various health needs, from preventive care to complex treatments. Pricing strategies are evolving in response to competitive pressures and consumer expectations, with a focus on delivering value through enhanced efficacy and customer satisfaction. In terms of competition benchmarking, prominent players are intensifying their efforts to differentiate through innovation and strategic partnerships. Regulatory influences play a pivotal role, with stringent guidelines shaping product development and market entry strategies. The market is also influenced by the increasing emphasis on animal welfare and the rising prevalence of zoonotic diseases. The competitive landscape is marked by the presence of multinational corporations and emerging regional players, each vying for a stronger foothold through technological advancements and expanded distribution networks.

Geographical Overview:

The Companion Animal Health Market is thriving across diverse regions, each showcasing unique growth dynamics. North America leads, driven by high pet ownership rates and advanced veterinary services. The region's focus on innovative healthcare solutions and preventive care enhances market growth. Europe follows, with a strong emphasis on pet welfare and regulatory frameworks supporting veterinary advancements. Increased spending on pet healthcare in this region further propels market expansion. In Asia Pacific, rapid urbanization and a growing middle class contribute to significant market growth. Rising pet adoption rates and increased awareness of animal health fuel demand for veterinary services. Emerging markets in Latin America and the Middle East & Africa present lucrative opportunities. In Latin America, economic development and rising disposable incomes drive the market. Meanwhile, the Middle East & Africa witness increasing investments in veterinary infrastructure, recognizing the importance of companion animal health in enhancing quality of life and economic growth.

Global tariffs and geopolitical tensions are significantly influencing the Companion Animal Health Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are navigating these challenges by enhancing domestic production capabilities and fostering innovation in veterinary pharmaceuticals and diagnostics. China's strategy is pivoting towards self-reliance, with increased investment in local manufacturing and research, while Taiwan leverages its robust biotech sector, although it remains vulnerable to cross-strait tensions. The global parent market is witnessing steady growth driven by rising pet ownership and advanced veterinary care. By 2035, the market is expected to thrive on technological advancements and strategic regional collaborations. Middle East conflicts could disrupt global supply chains and inflate energy prices, indirectly impacting production costs and market dynamics.

Key Trends and Drivers:

The Companion Animal Health Market is experiencing robust growth, propelled by rising pet ownership and increasing awareness of animal welfare. A significant trend is the surge in demand for advanced veterinary diagnostics and therapeutics, reflecting an emphasis on preventive care and early disease detection. Technological advancements, such as telemedicine and wearable health monitoring devices for pets, are transforming the landscape, offering convenience and improved health outcomes. Another key driver is the humanization of pets, with owners willing to invest in premium products and services. This trend is fostering innovation in areas like pet nutrition and personalized medicine. The expansion of veterinary clinics and pet healthcare infrastructure, particularly in emerging markets, is also contributing to market growth. Moreover, strategic partnerships and collaborations among industry players are facilitating the development of novel solutions and expanding market reach. Opportunities abound in the development of cost-effective treatments and diagnostic tools, particularly in regions with limited access to advanced veterinary care. Companies focusing on research and development to address specific health issues in companion animals are well-positioned to capitalize on these trends. The emphasis on sustainable and eco-friendly products is further shaping the market, aligning with broader consumer preferences for environmentally responsible choices.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Vaccines
    • 4.1.2 Pharmaceuticals
    • 4.1.3 Feed Additives
    • 4.1.4 Diagnostics
    • 4.1.5 Therapeutics
    • 4.1.6 Nutraceuticals
    • 4.1.7 Biologics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Veterinary Drugs
    • 4.2.2 Pet Food
    • 4.2.3 Animal Supplements
    • 4.2.4 Medical Devices
    • 4.2.5 Wearable Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Veterinary Clinics
    • 4.3.2 Pet Grooming
    • 4.3.3 Pet Boarding
    • 4.3.4 Pet Training
    • 4.3.5 Pet Insurance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Digital Health
    • 4.4.2 Telemedicine
    • 4.4.3 Wearable Technology
    • 4.4.4 Genomics
    • 4.4.5 Biotechnology
    • 4.4.6 Artificial Intelligence
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Disease Treatment
    • 4.6.2 Preventive Care
    • 4.6.3 Nutrition Management
    • 4.6.4 Rehabilitation
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Monitoring Devices
    • 4.7.2 Therapeutic Devices
    • 4.7.3 Diagnostic Devices
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Veterinary Hospitals
    • 4.8.2 Home Care Settings
    • 4.8.3 Research Institutes
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Clinical Solutions
    • 4.9.2 Operational Solutions
    • 4.9.3 Financial Solutions
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 In-Person
    • 4.10.2 Remote Monitoring
    • 4.10.3 Telehealth

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Device
      • 5.2.1.8 End User
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Device
      • 5.2.2.8 End User
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Device
      • 5.2.3.8 End User
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Device
      • 5.3.1.8 End User
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Device
      • 5.3.2.8 End User
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Device
      • 5.3.3.8 End User
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Device
      • 5.4.1.8 End User
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Device
      • 5.4.2.8 End User
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Device
      • 5.4.3.8 End User
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Device
      • 5.4.4.8 End User
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Device
      • 5.4.5.8 End User
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Device
      • 5.4.6.8 End User
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Device
      • 5.4.7.8 End User
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Device
      • 5.5.1.8 End User
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Device
      • 5.5.2.8 End User
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Device
      • 5.5.3.8 End User
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Device
      • 5.5.4.8 End User
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Device
      • 5.5.5.8 End User
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Device
      • 5.5.6.8 End User
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Device
      • 5.6.1.8 End User
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Device
      • 5.6.2.8 End User
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Device
      • 5.6.3.8 End User
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Device
      • 5.6.4.8 End User
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Device
      • 5.6.5.8 End User
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Vetoquinol
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dechra Pharmaceuticals
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Virbac
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Heska Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zoetis
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Elanco Animal Health
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Boehringer Ingelheim Animal Health
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ceva Sante Animale
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Phibro Animal Health
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 IDEXX Laboratories
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Merck Animal Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Bimeda
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Neogen Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Kyoritsu Seiyaku
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Ourofino Saude Animal
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Bio Chek
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Vetcare
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Norbrook Laboratories
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hipra
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Eco Animal Health
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us